Remuneration of Non-Executive Directors

RNS Number : 1215V
Futura Medical PLC
06 January 2012
 



For immediate release

6 January 2012

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

Remuneration of Non-Executive Directors

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces the introduction of a revised policy for the remuneration of its Non-Executive Directors including the Chairman Designate, John Clarke, under which they will receive approximately 30 per cent of their remuneration in the Company's ordinary shares.

Following a meeting yesterday of the Company's Remuneration Committee, it has been agreed that the shares for the current year's Non-Executive Directors' remuneration will be awarded at 84.10 pence per share, being the average closing mid-price of the  last 10 trading days. The Non-Executive Directors will receive the shares at the end of the 2012 financial year.

In future, shares that form part of Non-Executive Directors' remuneration will be awarded at the end of the financial year at a share price based on the average closing mid-price for the final 10 trading days of the previous financial year.

Full details of Non-Executive Directors' remuneration will be included in the Company's Annual Report & Accounts.

 

For any further information please contact:

 

Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0) 1483 685 670



mail to: james.barder@futuramedical.com

www.futuramedical.com



Nomura Code Securities Limited


Phil Walker / Giles Balleny

Tel:+44 (0) 20 7776 1200



For media enquiries please contact:




Buchanan


Mark Court / Jessica Fontaine

Tel: +44 (0) 20 7466 5000

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGGMRVMGZZG
UK 100

Latest directors dealings